Geode Capital Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $36.6M | Buy |
2,851,472
+155,285
| +6% | +$1.98M | ﹤0.01% | 1668 |
|
|
2025
Q4 | $24.2M | Buy |
2,696,187
+107,333
| +4% | +$1.48M | ﹤0.01% | 1897 |
|
|
2025
Q3 | $44.7M | Sell |
2,588,854
-17,368
| -0.7% | -$214K | ﹤0.01% | 1542 |
|
|
2025
Q2 | $24.4M | Buy |
2,606,222
+126,049
| +5% | +$1.04M | ﹤0.01% | 1852 |
|
|
2025
Q1 | $17.6M | Buy |
2,480,173
+90,933
| +4% | +$918K | ﹤0.01% | 1964 |
|
|
2024
Q4 | $27.9M | Buy |
2,389,240
+45,930
| +2% | +$717K | ﹤0.01% | 1780 |
|
|
2024
Q3 | $48.2M | Buy |
2,343,310
+49,367
| +2% | +$1.14M | ﹤0.01% | 1450 |
|
|
2024
Q2 | $51.3M | Buy |
2,293,943
+249,686
| +12% | +$5.95M | ﹤0.01% | 1349 |
|
|
2024
Q1 | $56.2M | Buy |
2,044,257
+70,988
| +4% | +$1.97M | 0.01% | 1273 |
|
|
2023
Q4 | $60.2M | Buy |
1,973,269
+93,024
| +5% | +$2.67M | 0.01% | 1222 |
|
|
2023
Q3 | $59.5M | Buy |
1,880,245
+94,298
| +5% | +$3.66M | 0.01% | 1117 |
|
|
2023
Q2 | $72.8M | Buy |
1,785,947
+130,556
| +8% | +$5.29M | 0.01% | 987 |
|
|
2023
Q1 | $61.7M | Buy |
1,655,391
+63,544
| +4% | +$2.49M | 0.01% | 1039 |
|
|
2022
Q4 | $55.5M | Buy |
1,591,847
+217,719
| +16% | +$10.4M | 0.01% | 1082 |
|
|
2022
Q3 | $76.9M | Buy |
1,374,128
+81,540
| +6% | +$5.06M | 0.01% | 804 |
|
|
2022
Q2 | $66.9M | Buy |
1,292,588
+65,764
| +5% | +$3.34M | 0.01% | 918 |
|
|
2022
Q1 | $89.2M | Sell |
1,226,824
-5,668
| -0.5% | -$480K | 0.01% | 848 |
|
|
2021
Q4 | $146M | Buy |
1,232,492
+35,402
| +3% | +$4.43M | 0.02% | 652 |
|
|
2021
Q3 | $161M | Buy |
1,197,090
+78,310
| +7% | +$11.9M | 0.02% | 591 |
|
|
2021
Q2 | $181M | Buy |
1,118,780
+97,742
| +10% | +$7.61M | 0.03% | 562 |
|
|
2021
Q1 | $81.9M | Buy |
1,021,038
+158,696
| +18% | +$10.7M | 0.01% | 883 |
|
|
2020
Q4 | $46.9M | Buy |
862,342
+120,906
| +16% | +$4.39M | 0.01% | 1143 |
|
|
2020
Q3 | $14.7M | Buy |
741,436
+86,081
| +13% | +$1.79M | ﹤0.01% | 1734 |
|
|
2020
Q2 | $13.8M | Buy |
655,355
+64,314
| +11% | +$1.09M | ﹤0.01% | 1740 |
|
|
2020
Q1 | $7.23M | Buy |
591,041
+42,478
| +8% | +$572K | ﹤0.01% | 1931 |
|
|
2019
Q4 | $8.05M | Sell |
548,563
-27,555
| -5% | -$383K | ﹤0.01% | 2158 |
|
|
2019
Q3 | $7.69M | Buy |
576,118
+72,033
| +14% | +$1.15M | ﹤0.01% | 2100 |
|
|
2019
Q2 | $8.25M | Buy |
504,085
+101,726
| +25% | +$1.6M | ﹤0.01% | 2075 |
|
|
2019
Q1 | $6.87M | Buy |
402,359
+42,880
| +12% | +$639K | ﹤0.01% | 2136 |
|
|
2018
Q4 | $4.91M | Buy |
359,479
+17,771
| +5% | +$330K | ﹤0.01% | 2242 |
|
|
2018
Q3 | $9.78M | Buy |
341,708
+79,623
| +30% | +$2.32M | ﹤0.01% | 1938 |
|
|
2018
Q2 | $7.17M | Buy |
262,085
+62,295
| +31% | +$1.51M | ﹤0.01% | 2109 |
|
|
2018
Q1 | $4.21M | Buy |
199,790
+3,865
| +2% | +$95.1K | ﹤0.01% | 2347 |
|
|
2017
Q4 | $3.77M | Buy |
195,925
+58,411
| +42% | +$1.35M | ﹤0.01% | 2380 |
|
|
2017
Q3 | $3.42M | Buy |
137,514
+43,911
| +47% | +$827K | ﹤0.01% | 2429 |
|
|
2017
Q2 | $1.5M | Buy |
93,603
+17,508
| +23% | +$245K | ﹤0.01% | 2894 |
|
|
2017
Q1 | $1.07M | Buy |
76,095
+4,291
| +6% | +$57.6K | ﹤0.01% | 2983 |
|
|
2016
Q4 | $941K | Buy |
71,804
+3,101
| +5% | +$46.6K | ﹤0.01% | 3023 |
|
|
2016
Q3 | $1.17M | Buy |
68,703
+1,357
| +2% | +$26.3K | ﹤0.01% | 2859 |
|
|
2016
Q2 | $1.44M | Buy |
+67,346
| New | +$1.79M | ﹤0.01% | 2698 |
|
Other funds holding NTLA
AIM
VPM
VCM
RP
